Multi-centric study for development and validation of a CT head rule for mild traumatic brain injury in direct oral anticoagulants: the HERO-M nomogram.


Journal

BMC emergency medicine
ISSN: 1471-227X
Titre abrégé: BMC Emerg Med
Pays: England
ID NLM: 100968543

Informations de publication

Date de publication:
15 10 2023
Historique:
received: 20 12 2022
accepted: 08 09 2023
medline: 23 10 2023
pubmed: 16 10 2023
entrez: 15 10 2023
Statut: epublish

Résumé

Nomograms are easy-to-handle clinical tools which can help in estimating the risk of adverse outcome in certain population. This multi-center study aims to create and validate a simple and usable clinical prediction nomogram for individual risk of post-traumatic Intracranial Hemorrhage (ICH) after Mild Traumatic Brain Injury (MTBI) in patients treated with Direct Oral Anticoagulants (DOACs). From January 1, 2016 to December 31, 2019, all patients on DOACs evaluated for an MTBI in five Italian Emergency Departments were enrolled. A training set to develop the nomogram and a test set for validation were identified. The predictive ability of the nomogram was assessed using AUROC, calibration plot, and decision curve analysis. Of the 1425 patients in DOACs in the study cohort, 934 (65.5%) were included in the training set and 491 (34.5%) in the test set. Overall, the rate of post-traumatic ICH was 6.9% (7.0% training and 6.9% test set). In a multivariate analysis, major trauma dynamic (OR: 2.73, p = 0.016), post-traumatic loss of consciousness (OR: 3.78, p = 0.001), post-traumatic amnesia (OR: 4.15, p < 0.001), GCS < 15 (OR: 3.00, p < 0.001), visible trauma above the clavicles (OR: 3. 44, p < 0.001), a post-traumatic headache (OR: 2.71, p = 0.032), a previous history of neurosurgery (OR: 7.40, p < 0.001), and post-traumatic vomiting (OR: 3.94, p = 0.008) were independent risk factors for ICH. The nomogram demonstrated a good ability to predict the risk of ICH (AUROC: 0.803; CI95% 0.721-0.884), and its clinical application showed a net clinical benefit always superior to performing CT on all patients. The Hemorrhage Estimate Risk in Oral anticoagulation for Mild head trauma (HERO-M) nomogram was able to predict post-traumatic ICH and can be easily applied in the Emergency Department (ED).

Sections du résumé

BACKGROUND
Nomograms are easy-to-handle clinical tools which can help in estimating the risk of adverse outcome in certain population. This multi-center study aims to create and validate a simple and usable clinical prediction nomogram for individual risk of post-traumatic Intracranial Hemorrhage (ICH) after Mild Traumatic Brain Injury (MTBI) in patients treated with Direct Oral Anticoagulants (DOACs).
METHODS
From January 1, 2016 to December 31, 2019, all patients on DOACs evaluated for an MTBI in five Italian Emergency Departments were enrolled. A training set to develop the nomogram and a test set for validation were identified. The predictive ability of the nomogram was assessed using AUROC, calibration plot, and decision curve analysis.
RESULTS
Of the 1425 patients in DOACs in the study cohort, 934 (65.5%) were included in the training set and 491 (34.5%) in the test set. Overall, the rate of post-traumatic ICH was 6.9% (7.0% training and 6.9% test set). In a multivariate analysis, major trauma dynamic (OR: 2.73, p = 0.016), post-traumatic loss of consciousness (OR: 3.78, p = 0.001), post-traumatic amnesia (OR: 4.15, p < 0.001), GCS < 15 (OR: 3.00, p < 0.001), visible trauma above the clavicles (OR: 3. 44, p < 0.001), a post-traumatic headache (OR: 2.71, p = 0.032), a previous history of neurosurgery (OR: 7.40, p < 0.001), and post-traumatic vomiting (OR: 3.94, p = 0.008) were independent risk factors for ICH. The nomogram demonstrated a good ability to predict the risk of ICH (AUROC: 0.803; CI95% 0.721-0.884), and its clinical application showed a net clinical benefit always superior to performing CT on all patients.
CONCLUSION
The Hemorrhage Estimate Risk in Oral anticoagulation for Mild head trauma (HERO-M) nomogram was able to predict post-traumatic ICH and can be easily applied in the Emergency Department (ED).

Identifiants

pubmed: 37840139
doi: 10.1186/s12873-023-00884-w
pii: 10.1186/s12873-023-00884-w
pmc: PMC10578033
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

J Emerg Med. 2015 Feb;48(2):137-42
pubmed: 25440860
Chest. 2016 Feb;149(2):315-352
pubmed: 26867832
BMJ Open. 2016 Dec 13;6(12):e013742
pubmed: 27974370
J Trauma Acute Care Surg. 2015 Mar;78(3):614-21
pubmed: 25710435
Acad Emerg Med. 1999 Feb;6(2):121-4
pubmed: 10051903
J Neurol Surg A Cent Eur Neurosurg. 2017 Sep;78(5):478-487
pubmed: 28482371
J Am Geriatr Soc. 2020 May;68(5):977-982
pubmed: 32142155
Ann Emerg Med. 2002 Nov;40(5):505-14
pubmed: 12399794
Emerg Med J. 2020 Nov;37(11):666-673
pubmed: 32900858
J Clin Neurosci. 2009 Jul;16(7):882-5
pubmed: 19342242
Bull Emerg Trauma. 2019 Jul;7(3):269-277
pubmed: 31392227
JAMA. 2015 Dec 22-29;314(24):2672-81
pubmed: 26717031
Ann Intern Med. 2007 Mar 20;146(6):397-405
pubmed: 17371884
Dtsch Arztebl Int. 2016 Sep 5;113(35-36):575-82
pubmed: 27658470
Arch Acad Emerg Med. 2020 Sep 08;8(1):e79
pubmed: 33244515
Arch Dis Child Educ Pract Ed. 2015 Apr;100(2):97-100
pubmed: 25335757
Br J Haematol. 2018 Oct;183(1):119-126
pubmed: 30028001
Eur J Neurol. 2002 May;9(3):207-19
pubmed: 11985628
World Neurosurg. 2018 Feb;110:e339-e345
pubmed: 29129761
Am J Emerg Med. 2021 Dec;50:388-393
pubmed: 34478944
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029621996810
pubmed: 33783251
J Trauma Acute Care Surg. 2020 Jan;88(1):186-194
pubmed: 31688828
J Neurotrauma. 2001 Jul;18(7):657-64
pubmed: 11497092
J Neurotrauma. 2018 Mar 1;35(5):750-759
pubmed: 29108469
Ann Emerg Med. 2019 Jan;73(1):66-75
pubmed: 30236417
N Engl J Med. 2000 Jul 13;343(2):100-5
pubmed: 10891517
J Emerg Med. 2019 Dec;57(6):817-824
pubmed: 31648805
J Thromb Thrombolysis. 2020 Nov;50(4):913-920
pubmed: 32281069
Ann Emerg Med. 2001 Aug;38(2):160-9
pubmed: 11468612
Thromb Res. 2019 Feb;174:113-120
pubmed: 30593997
Intern Emerg Med. 2021 Jun;16(4):1061-1070
pubmed: 33386604
Am J Emerg Med. 2022 Sep;59:121-128
pubmed: 35841845

Auteurs

Naria Park (N)

Emergency Medicine Department, Pisa University Hospital, Pisa, Italy.

Greta Barbieri (G)

Emergency Medicine Department, Pisa University Hospital, Pisa, Italy. greta.barbieri@phd.unipi.it.
Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Via Savi, Pisa, 10 - 56126, Italy. greta.barbieri@phd.unipi.it.

Gianni Turcato (G)

Emergency Department, Hospital of Merano, Merano, Italy.

Alessandro Cipriano (A)

Emergency Medicine Department, Pisa University Hospital, Pisa, Italy.

Arian Zaboli (A)

Emergency Department, Hospital of Merano, Merano, Italy.

Sara Giampaoli (S)

Emergency Medicine Department, Pisa University Hospital, Pisa, Italy.

Antonio Bonora (A)

Emergency Department, University of Verona, Verona, Italy.

Giorgio Ricci (G)

Emergency Department, University of Verona, Verona, Italy.

Massimo Santini (M)

Emergency Medicine Department, Pisa University Hospital, Pisa, Italy.

Lorenzo Ghiadoni (L)

Emergency Medicine Department, Pisa University Hospital, Pisa, Italy.
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH